| |
Many protein pharmaceuticals being
developed for human use
are glycoproteins, with oligosaccharides
covalently attached to the polypeptide side chains. The proportion
of a glycoprotein
which is oligosaccharide varies. Increasing
evidence suggests
that oligosaccharides can play an important
role in glyco-protein function. In evaluating the therapeutic
effect and safety
of a glycoprotein pharmaceutical, the intrinsic
properties
of the oligosaccharides as well as their modulating
effect on
the
protein must be considered and controlled.
novatec analytical
is dedicated to supply the biopharma
com- munity with the tools
required for the analysis of
recombinant biotherapeutics.
Our product line
consists of:
|
Labeling Kits (sufficient reagents for up
to 12-36 samples) |
|
|
|
|
LudgerTag 2-AB Labeling Kit |
LT-KAB-A2 |
|
LudgerTag 2-AA Labeling Kit |
LT-KAA-A2 |
|
LudgerTag AA-AC Labeling Kit |
LT-KAAC-A2 |
|
LudgerTag 2-AP Labeling Kit |
LT-KAP-A2 |
|
|
|
CleanUp Cartridges
(each 6 Cartridges) |
|
|
|
|
LudgerClean E10 Cartridges |
LC-E10-A6 |
|
LudgerClean S Cartridges |
LC-S-A6 |
|
|
|
Carbohydrate HPLC Columns |
|
|
|
|
|
LudgerSep N HPLC Column |
LS-N1-4.6x250 |
|
LudgerSep C HPLC Column |
LC-C1-4.6x100 |
|
LudgerSep R HPLC Column |
LC-R1-4.6x150 |
|
|
|
|
Hydrazine |
|
|
|
|
|
Anhydrous Hydrazine (10 x 500 µl ampules) |
LK-HYDRAZINE-A10 |
|
|
|
|
Enzyme-Kits |
|
|
|
|
|
Carbohydrate N-Sequencing Kit |
KE-SQ01 |
|
Enzymatic CarboRelease Kit |
KE-DG01 |
|
|
|
|
Enzymes |
|
|
|
|
|
Endoglycosidases |
|
|
|
|
|
PNGaseF, 300 mU, 60 µl |
E-PNG01 |
|
PNGaseF, 1U, 200 µl |
E-PNG05 |
|
PNGaseF, High Concentration, 1 U, 40 µl |
E-PNG09 |
|
Endo F1,1 U, 60 µl |
E-EF01 |
|
Endo F2, 1 U, 60 µl |
E-EF02 |
|
Endo F3, 330 mU, 60 µl |
E-EF03 |
|
Endo H, 300 mU, 60 µl |
E-EH02 |
|
O-Glycosidase, 75 mU, 60 µl |
E-G001 |
|
|
|
|
Exoglycosidases |
|
|
|
|
|
Sialidase AU, a-(2-3,6,8,9), 300 mU, 60
µl |
E-S001 |
|
Sialidase CP, a-(2-3,6), 900 mU, 60 µl |
E-S005 |
|
Sialidase SP, a-(2-3),300 mU, 60 µl |
E-S007 |
|
α-(1-3,6)-Galactosidase, 24 U, 60 µl |
E-AG01 |
|
ß-(1-3,4,6)-Galactosidase, 360 mU, 60 µl |
E-BG01 |
|
ß-(1-3,4)-Galactosidase, 500 mU, 200 µl |
E-BG02 |
|
ß-(1-3,6)-Galactosidase, 3 U, 60 µl |
E-BG05 |
|
ß-(1-4)-Galactosidase, 180 mU, 60 µl |
E-BG07 |
|
Glucosaminidase, 2.4 U, 60 µl |
E-GL01 |
|
α-(1-2,3,6)-Mannosidase, 480 mU, 60 µl |
E-AM01 |
|
α-(1-6)-Mannosidase, 60 mU, 60 µl |
E-AM02 |
|
α-(1-3,4)-Fucosidase, 30 mU, 60 µl |
E-F002 |
|
α-(1-6)-Fucosidase, 30 mU, 60 µl |
E-F006 |
|
|
|
|
|
|
|
Carbohydrate Standards & Controls |
|
|
CarboLadder (Wheat starch ladder), 20 µg |
SA-L001 |
|
Fetuin, Control, 0.5 mg |
SA-F001 |
|
|
|
|
O-Linked Core 1 Glycan |
|
|
Galactose-β
(1-3)-GalNAc Glycan, 20 µg |
SA-CORE1 |
|
|
|
|
A4 Glycans |
|
|
NA4 Glycan, 20 µg |
CN-NA4-20U |
|
NGA4 Glycan, 20 µg |
CN-NGA4-20U |
|
|
|
|
A3 Glycans |
|
|
A3 Glycan, 20 µg |
CN-A3-20U |
|
NA3 Glycan, 20 µg |
CN-NA3-20U |
|
NGA3 Glycan, 20 µg |
CN-NGA3-20U |
|
|
|
|
A2F Glycans |
|
|
A2F Glycan |
CN-A2F-20U |
|
A1F Glycan, 20 µg |
CN-A1F-20U |
|
NA2F Glycan, 20 µg |
CN-NA2F-20U |
|
NGA2F Glycan, 20 µg |
CN-NGA2F-20U |
|
|
|
|
A2 Glycans |
|
|
A2 Glycan, 20 µg |
CN-A2-20U |
|
A1 Glycan, 20 µg |
CN-A1-20U |
|
NA2 Glycan, 20 µg |
CN-NA2-20U |
|
NGA2 Glycan, 20 µg |
CN-NGA2-20U |
|
M3N2 Glycan, 20 µg |
CN-M3N2-20U |
|
|
|
|
Miscellaneous Glycans |
|
|
Hybrid Glycan, 20 µg |
CN-HYBRID-20U |
|
|
|
|
Oligomannose Glycans |
|
|
Man-9 Glycan, 20 µg |
CN-MAN9-20U |
|
Man-8 Glycan, 20 µg |
CN-MAN8-20U |
|
Man-7 Glycan, 20 µg |
CN-MAN7-20U |
|
Man-6 Glycan, 20 µg |
CN-MAN6-20U |
|
Man-5 Glycan, 20 µg |
CN-MAN5-20U |
|
|
|
|
Analytical Services |
|
|
|
|
Please get in touch with us and inquire
a quotation for your specific application
|
|
